|
1
|
Zhang C, Stampfl-Mattersberger M, Ruckser
R and Sebesta C: Colorectal cancer. Wien Med Wochenschr.
173:216–220. 2023.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu CY, Han JX, Zhang J, Jiang P, Shen C,
Guo F, Tang J, Yan T, Tian X, Zhu X, et al: A 16q22.1 variant
confers susceptibility to colorectal cancer as a distal regulator
of ZFP90. Oncogene. 39:1347–1360. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chaplin A, Rodriguez RM, Segura-Sampedro
JJ, Ochogavía-Seguí A, Romaguera D and Barceló-Coblijn G: Insights
behind the relationship between colorectal cancer and obesity: Is
visceral adipose tissue the missing link. Int J Mol Sci.
23:131282022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sawicki T, Ruszkowska M, Danielewicz A,
Niedźwiedzka E, Arłukowicz T and Przybyłowicz KE: A review of
colorectal cancer in terms of epidemiology, risk factors,
development, symptoms and diagnosis. Cancers (Basel). 13:20252021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang F, Sun N, Zeng H, Gao Y, Zhang N and
Zhang W: Selenium deficiency leads to inflammation, autophagy,
endoplasmic reticulum stress, apoptosis and contraction
abnormalities via affecting intestinal flora in intestinal smooth
muscle of mice. Front Immunol. 13:9476552022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang Y, Zhang X, Wang Y, Guo Y, Zhu P, Li
G, Zhang J, Ma Q and Zhao L: Dietary ellagic acid ameliorated
Clostridium perfringens-induced subclinical necrotic enteritis in
broilers via regulating inflammation and cecal microbiota. J Anim
Sci Biotechnol. 13:472022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Masheghati F, Asgharzadeh MR, Jafari A,
Masoudi N and Maleki-Kakelar H: The role of gut microbiota and
probiotics in preventing, treating, and boosting the immune system
in colorectal cancer. Life Sci. 344:1225292024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu Y, Luo X, Yang D, Li Y, Gong T, Li B,
Cheng J, Chen R, Guo X and Yuan W: Effects of probiotic
supplementation on related side effects after chemoradiotherapy in
cancer patients. Front Oncol. 12:10321452022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lehouritis P, Stanton M, McCarthy FO,
Jeavons M and Tangney M: Activation of multiple chemotherapeutic
prodrugs by the natural enzymolome of tumour-localised probiotic
bacteria. J Control Release. 222:9–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong H, Wang J, Chang Z, Hu H, Yuan Z,
Zhu Y, Hu Z, Wang C, Liu Y, Wang Y, et al: Gut microbiota display
alternative profiles in patients with early-onset colorectal
cancer. Front Cell Infect Microbiol. 12:10369462022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sánchez-Alcoholado L, Laborda-Illanes A,
Otero A, Ordóñez R, González-González A, Plaza-Andrades I,
Ramos-Molina B, Gómez-Millán J and Queipo-Ortuño MI: Relationships
of gut microbiota composition, short-chain fatty acids and
polyamines with the pathological response to neoadjuvant
radiochemotherapy in colorectal cancer patients. Int J Mol Sci.
22:95492021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bi D, Zhu Y, Gao Y, Li H, Zhu X, Wei R,
Xie R, Cai C, Wei Q and Qin H: Profiling fusobacterium infection at
high taxonomic resolution reveals lineage-specific correlations in
colorectal cancer. Nat Commun. 13:33362022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castro-Mejía JL, O'Ferrall S, Krych Ł,
O'Mahony E, Namusoke H, Lanyero B, Kot W, Nabukeera-Barungi N,
Michaelsen KF, Mølgaard C, et al: Restitution of gut microbiota in
Ugandan children administered with probiotics (Lactobacillus
rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12)
during treatment for severe acute malnutrition. Gut Microbes.
11:855–867. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park YE and Kim JH: Revolutionizing gut
health: exploring the role of gut microbiota and the potential of
microbiome-based therapies in lower gastrointestinal diseases.
Kosin Med J. 38:98–106. 2023. View Article : Google Scholar
|
|
15
|
Sobhani I, Tap J, Roudot-Thoraval F,
Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J and
Furet JP: Microbial dysbiosis in colorectal cancer (CRC) patients.
PLoS One. 6:e163932011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fong W, Li Q and Yu J: Gut microbiota
modulation: A novel strategy for prevention and treatment of
colorectal cancer. Oncogene. 39:4925–4943. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng Y, Ling Z and Li L: The intestinal
microbiota and colorectal cancer. Front Immunol. 11:6150562020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grigoryan H, Schiffman C, Gunter MJ,
Naccarati A, Polidoro S, Dagnino S, Dudoit S, Vineis P and
Rappaport SM: Cys34 adductomics links colorectal cancer with the
gut microbiota and redox biology. Cancer Res. 79:6024–6031. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ying HQ, Chen W, Xiong CF, Wang Y, Li XJ
and Cheng XX: Quantification of fibrinogen-to-pre-albumin ratio
provides an integrating parameter for differential diagnosis and
risk stratification of early-stage colorectal cancer. Cancer Cell
Int. 22:1372022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song C, Duan F, Ju T, Qin Y, Zeng D, Shan
S, Shi Y, Zhang Y and Lu W: Eleutheroside E supplementation
prevents radiation-induced cognitive impairment and activates PKA
signaling via gut microbiota. Commun Biol. 5:6802022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li R, Huang X, Yang L, Liang X, Huang W,
Lai KP and Zhou L: Integrated analysis reveals the targets and
mechanisms in immunosuppressive effect of mesalazine on ulcerative
colitis. Front Nutr. 9:8676922022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan H, Hao X, Gao Y, Yang J, Liu A, Su Y
and Xia Y: Nodosin exerts an anti-colorectal cancer effect by
inhibiting proliferation and triggering complex cell death in vitro
and in vivo. Front Pharmacol. 13:9432722022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wan F, Zhong R, Wang M, Zhou Y, Chen Y, Yi
B, Hou F, Liu L, Zhao Y, Chen L and Zhang H: Caffeic acid
supplement alleviates colonic inflammation and oxidative stress
potentially through improved gut microbiota community in mice.
Front Microbiol. 12:7842112021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Krieg C, Weber LM, Fosso B, Marzano M,
Hardiman G, Olcina MM, Domingo E, El Aidy S, Mallah K, Robinson MD
and Guglietta S: Complement downregulation promotes an inflammatory
signature that renders colorectal cancer susceptible to
immunotherapy. J Immunother Cancer. 10:e0047172022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leonard WJ and Spolski R: Interleukin-21:
A modulator of lymphoid proliferation, apoptosis and
differentiation. Nat Rev Immunol. 5:688–698. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahashi J, Yamamoto M, Yasukawa H,
Nohara S, Nagata T, Shimozono K, Yanai T, Sasaki T, Okabe K,
Shibata T, et al: Interleukin-22 directly activates myocardial
STAT3 (Signal Transducer and Activator of Transcription-3)
signaling pathway and prevents myocardial ischemia reperfusion
injury. J Am Heart Assoc. 9:e0148142020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiao Z, Liu L, Pei X, Sun W, Jin Y, Yang
ST and Wang M: A potential probiotic for diarrhea: Clostridium
tyrobutyricum protects against LPS-induced epithelial dysfunction
via IL-22 Produced By Th17 cells in the ileum. Front Immunol.
12:7582272021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Q, Cheng X, Guo J, Bi Y, Kuang L, Ren
J, Zhong J, Pan L, Zhang X, Guo Y, et al: MLKL inhibits intestinal
tumorigenesis by suppressing STAT3 signaling pathway. Int J Biol
Sci. 17:869–881. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiaoyu P, Chao G, Lihua D and Pengyu C:
Gut bacteria affect the tumoral immune milieu: Distorting the
efficacy of immunotherapy or not? Gut Microbes. 11:691–705. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karstens KF, Kempski J, Giannou AD,
Pelczar P, Steglich B, Steurer S, Freiwald E, Woestemeier A,
Konczalla L, Tachezy M, et al: Anti-inflammatory microenvironment
of esophageal adenocarcinomas negatively impacts survival. Cancer
Immunol Immunother. 6:1043–1056. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liou CJ, Chen YL, Yu MC, Yeh KW, Shen SC
and Huang WC: Sesamol alleviates airway hyperresponsiveness and
oxidative stress in asthmatic mice. Antioxidants (Basel).
9:2952020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang H, Huang J, Ding Y, Zhou J, Gao G,
Han H, Zhou J, Ke L, Rao P, Chen T and Zhang L: Nanoparticles
isolated from porcine bone soup ameliorated dextran sulfate
sodium-induced colitis and regulated gut microbiota in mice. Front
Nutr. 9:8214042022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang K, Guo J, Chang X and Gui S:
Painong-san extract alleviates dextran sulfate sodium-induced
colitis in mice by modulating gut microbiota, restoring intestinal
barrier function and attenuating TLR4/NF-κB signaling cascades. J
Pharm Biomed Anal. 209:1145292022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bai J, Zhao J, Al-Ansi W, Wang J, Xue L,
Liu J, Wang Y, Fan M, Qian H, Li Y and Wang L: Oat β-glucan
alleviates DSS-induced colitis via regulating gut microbiota
metabolism in mice. Food Funct. 12:8976–8993. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu S, Rhee KJ, Albesiano E, Rabizadeh S,
Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al: A
human colonic commensal promotes colon tumorigenesis via activation
of T helper type 17 T cell responses. Nat Med. 15:1016–1022. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tian L, Long F, Hao Y, Li B, Li Y, Tang Y,
Li J, Zhao Q, Chen J and Liu M: A cancer associated
fibroblasts-related six-gene panel for anti-PD-1 therapy in
melanoma driven by weighted correlation network analysis and
supervised machine learning. Front Med (Lausanne). 9:8803262022.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nyiramana MM, Cho SB, Kim EJ, Kim MJ, Ryu
JH, Nam HJ, Kim NG, Park SH, Choi YJ, Kang SS, et al: Sea hare
hydrolysate-induced reduction of human non-small cell lung cancer
cell growth through regulation of macrophage polarization and
non-apoptotic regulated cell death pathways. Cancers (Basel).
12:7262020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dmitrieva-Posocco O, Dzutsev A, Posocco
DF, Hou V, Yuan W, Thovarai V, Mufazalov IA, Gunzer M, Shilovskiy
IP, Khaitov MR, et al: Cell-type-specific responses to
interleukin-1 control microbial invasion and tumor-elicited
inflammation in colorectal cancer. Immunity. 50:166–180.e7. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hahn YI, Saeidi S, Kim SJ, Park SY, Song
NY, Zheng J, Kim DH, Lee HB, Han W, Noh DY, et al: STAT3 stabilizes
IKKα protein through direct interaction in transformed and
cancerous human breast epithelial cells. Cancers (Basel).
13:822020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Franz A, Coscia F, Shen C, Charaoui L,
Mann M and Sander C: Molecular response to PARP1 inhibition in
ovarian cancer cells as determined by mass spectrometry based
proteomics. J Ovarian Res. 14:1402021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pan Z, He Y, Zhu W, Xu T, Hu X and Huang
P: A dynamic transcription factor signature along the colorectal
adenoma-carcinoma sequence in patients with co-occurrent adenoma
and carcinoma. Front Oncol. 11:5974472021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Icard P, Fournel L, Wu Z, Alifano M and
Lincet H: Interconnection between metabolism and cell cycle in
cancer. Trends Biochem Sci. 44:490–501. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tian X, Wei W, Cao Y, Ao T, Huang F, Javed
R, Wang X, Fan J, Zhang Y, Liu Y, et al: Gingival mesenchymal stem
cell-derived exosomes are immunosuppressive in preventing
collagen-induced arthritis. J Cell Mol Med. 26:693–708. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim BR, Ha J, Kang E and Cho S: Regulation
of signal transducer and activator of transcription 3 activation by
dual-specificity phosphatase3. BMB Rep. 53:335–340. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang M, Dai Z, Zhao X, Wang G and Lai R:
Anticarin β inhibits human glioma progression by suppressing cancer
stemness via STAT3. Front Oncol. 11:7156732021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shen J, Zhang M, Zhang K, Qin Y, Liu M,
Liang S, Chen D and and Peng M: Effect of Angelica polysaccharide
on mouse myeloid-derived suppressor cells. Front Immunol.
13:9892302022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Al-Warhi T, Al-Karmalawy AA, Elmaaty AA,
Alshubramy MA, Abdel-Motaal M, Majrashi TA, Asem M, Nabil A,
Eldehna WM and Sharaky M: Biological evaluation, docking studies,
and in silico ADME prediction of some pyrimidine and pyridine
derivatives as potential EGFR WT and EGFR
T790M inhibitors. J Enzyme Inhib Med Chem. 38:176–191.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yu J, Li S, Guo J, Xu Z, Zheng J and Sun
X: Farnesoid X receptor antagonizes Wnt/β-catenin signaling in
colorectal tumorigenesis. Cell Death Dis. 11:6402020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
McPherson J, Hu C, Begum K, Wang W,
Lancaster C, Gonzales-Luna AJ, Loveall C, Silverman MH, Alam MJ and
Garey KW: Functional and metagenomic evaluation of ibezapolstat for
early evaluation of anti-recurrence effects in clostridioides
difficile infection. Antimicrob Agents Chemother. 66:e02244212022.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bernstein H, Bernstein C, Payne CM and
Dvorak K: Bile acids as endogenous etiologic agents in
gastrointestinal cancer. World J Gastroenterol. 15:3329–3340. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang X, Ye P, Fang L, Ge S, Huang F,
Polverini PJ, Heng W, Zheng L, Hu Q, Yan F and Wang W: Active
smoking induces aberrations in digestive tract microbiota of rats.
Front Cell Infect Microbiol. 11:7372042021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Maarsingh JD, Łaniewski P and
Herbst-Kralovetz MM: Immunometabolic and potential tumor-promoting
changes in 3D cervical cell models infected with bacterial
vaginosis-associated bacteria. Commun Biol. 5:7252022. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sánchez-Quintero MJ, Rodríguez-Díaz C,
Rodríguez-González FJ, Fernández-Castañer A, García-Fuentes E and
López-Gómez C: Role of mitochondria in inflammatory bowel diseases:
A systematic review. Int J Mol Sci. 24:171242023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Huang D, Jing G and Zhu S: Regulation of
mitochondrial respiration by hydrogen sulfide. Antioxidants
(Basel). 12:16442023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Blachier F, Andriamihaja M, Larraufie P,
Ahn E, Lan A and Kim E: Production of hydrogen sulfide by the
intestinal microbiota and epithelial cells and consequences for the
colonic and rectal mucosa. Am J Physiol Gastrointest Liver Physiol.
320:G125–G135. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Roudsari LC and West JL: Studying the
influence of angiogenesis in in vitro cancer model systems. Adv
Drug Deliv Rev. 97:250–259. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang Z, Lan R, Xu Y, Zuo J, Han X,
Phouthapane V, Luo Z and Miao J: Taurine alleviates streptococcus
uberis-induced inflammation by activating autophagy in mammary
epithelial cells. Front Immunol. 12:6311132021. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Karpiński TM, Ożarowski M and Stasiewicz
M: Carcinogenic microbiota and its role in colorectal cancer
development. Semin Cancer Biol. 86:420–430. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang S, Bian H, Li X, Wu H, Bi Q, Yan Y
and Wang Y: Hydrogen sulfide promotes cell proliferation of oral
cancer through activation of the COX2/AKT/ERK1/2 axis. Oncol Rep.
35:2825–2832. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kelly D, Yang L and Pei Z: Gut microbiota,
fusobacteria, and colorectal cancer. Diseases. 6:1092018.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kiziltan T, Baran A, Kankaynar M, Şenol O,
Sulukan E, Yildirim S and Ceyhun SB: Effects of the food colorant
carmoisine on zebrafish embryos at a wide range of concentrations.
Arch Toxicol. 96:1089–1099. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Bulanda S and Janoszka B: Consumption of
thermally processed meat containing carcinogenic compounds
(Polycyclic Aromatic Hydrocarbons and Heterocyclic Aromatic Amines)
versus a risk of some cancers in humans and the possibility of
reducing their formation by natural food additives-a literature
review. Int J Environ Res Public Health. 19:47812022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liu R, Lin X, Li Z, Li Q and Bi K:
Quantitative metabolomics for investigating the value of polyamines
in the early diagnosis and therapy of colorectal cancer.
Oncotarget. 9:4583–4592. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Meng X, Peng J, Xie X, Yu F, Wang W, Pan
Q, Jin H, Huang X, Yu H, Li S, et al: Roles of lncRNA LVBU in
regulating urea cycle/polyamine synthesis axis to promote
colorectal carcinoma progression. Oncogene. 41:4231–4243. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Auvray F, Perrat A, Arimizu Y, Chagneau
CV, Bossuet-Greif N, Massip C, Brugère H, Nougayrède JP, Hayashi T,
Branchu P, et al: Insights into the acquisition of the pks island
and production of colibactin in the Escherichia coli population.
Microb Genom. 7:0005792021.PubMed/NCBI
|
|
66
|
Chagneau CV, Payros D, Tang-Fichaux M,
Auvray F, Nougayrède JP and Oswald E: The pks island: A bacterial
swiss army knife? Colibactin: Beyond DNA damage and cancer. Trends
Microbiol. 30:1146–1159. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wami H, Wallenstein A, Sauer D, Stoll M,
von Bünau R, Oswald E, Müller R and Dobrindt U: Insights into
evolution and coexistence of the colibactin-and yersiniabactin
secondary metabolite determinants in enterobacterial populations.
Microb Genom. 7:0005772021.PubMed/NCBI
|
|
68
|
Lopès A, Billard E, Casse AH, Villéger R,
Veziant J, Roche G, Carrier G, Sauvanet P, Briat A, Pagès F, et al:
Colibactin-positive Escherichia coli induce a procarcinogenic
immune environment leading to immunotherapy resistance in
colorectal cancer. Int J Cancer. 146:3147–3159. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Salesse L, Lucas C, Hoang MHT, Sauvanet P,
Rezard A, Rosenstiel P, Damon-Soubeyrand C, Barnich N, Godfraind C,
Dalmasso G and Nguyen HTT: Colibactin-producing escherichia coli
induce the formation of invasive carcinomas in a chronic
inflammation-associated mouse model. Cancers (Basel). 13:20602021.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Dahmus JD, Kotler DL, Kastenberg DM and
Kistler CA: The gut microbiome and colorectal cancer: A review of
bacterial pathogenesis. J Gastrointest Oncol. 9:769–777. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Oh H, Kim J, Park J, Choi Z, Hong J, Jeon
BY, Ka H and Hong M: Structure-based molecular characterization of
a putative aspartic proteinase from Bacteroides fragilis. Biochem
Biophys Res Commun. 738:1505472024. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lee CG, Hwang S, Gwon SY, Park C, Jo M,
Hong JE and Rhee KJ: Bacteroides fragilis toxin induces intestinal
epithelial cell secretion of interleukin-8 by the
E-Cadherin/β-Catenin/NF-κB dependent pathway. Biomedicines.
10:8272022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Valguarnera E and Wardenburg JB: Good gone
bad: One toxin away from disease for bacteroides fragilis. J Mol
Biol. 432:765–785. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ko SH, Jeon JI, Woo HA and Kim JM:
Bacteroides fragilis enterotoxin upregulates heme oxygenase-1 in
dendritic cells via reactive oxygen species-, mitogen-activated
protein kinase-, and Nrf2-dependent pathway. World J Gastroenterol.
26:291–306. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Bao Y, Tang J, Qian Y, Sun T, Chen H, Chen
Z, Sun D, Zhong M, Chen H, Hong J, et al: Long noncoding RNA BFAL1
mediates enterotoxigenic Bacteroides fragilis-related
carcinogenesis in colorectal cancer via the RHEB/mTOR pathway. Cell
Death Dis. 10:6752019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Goodwin AC, Destefano Shields CE, Wu S,
Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S,
Woster PM, Sears CL and Casero RA Jr: Polyamine catabolism
contributes to enterotoxigenic Bacteroides fragilis-induced colon
tumorigenesis. Proc Natl Acad Sci USA. 108:15354–15359. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Thiele Orberg E, Fan H, Tam AJ, Dejea CM,
Destefano Shields CE, Wu S, Chung L, Finard BB, Wu X, Fathi P, et
al: The myeloid immune signature of enterotoxigenic Bacteroides
fragilis-induced murine colon tumorigenesis. Mucosal Immunol.
10:421–433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Knippel RJ, Drewes JL and Sears CL: The
cancer microbiome: recent highlights and knowledge gaps. Cancer
Discov. 11:2378–2395. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Grivennikov SI, Wang K, Mucida D, Stewart
CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung
KE, et al: Adenoma-linked barrier defects and microbial products
drive IL-23/IL-17-mediated tumour growth. Nature. 491:254–258.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang J, Wu S, Wang Q, Yuan Q, Li Y,
Reboredo-Rodríguez P, Varela-López A, He Z, Wu F, Hu H and Liu X:
Oxidative stress amelioration of novel peptides extracted from
enzymatic hydrolysates of Chinese pecan cake. Int J Mol Sci.
23:120862022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhang L, Yang L, Luo Y, Dong L and Chen F:
Acrylamide-induced hepatotoxicity through oxidative stress:
mechanisms and interventions. Antioxid Redox Signal. 38:1122–1137.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kong Y, Li M, Liang G, Linhai Y, Li S,
Zhuang Y, Ruomin L, Xiumei C and Guiqin W: Effects of dietary
curcumin inhibit deltamethrin-induced oxidative stress,
inflammation and cell apoptosis in Channa argus via Nrf2 and NF-κB
signaling pathways. Aquaculture. 540:7367442021. View Article : Google Scholar
|
|
83
|
Luan C, Lu Z, Chen J, Chen M, Zhao R and
Li X: Thalidomide alleviates apoptosis, oxidative damage and
inflammation induced by pemphigus vulgaris IgG in HaCat cells and
neonatal mice through MyD88. Drug Des Devel Ther. 17:2821–2839.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Wu J, Li Q and Fu X: Fusobacterium
nucleatum contributes to the carcinogenesis of colorectal cancer by
inducing inflammation and suppressing host immunity. Transl Oncol.
12:846–851. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Dariya B, Aliya S, Merchant N, Alam A and
Nagaraju GP: Colorectal cancer biology, diagnosis, and therapeutic
approaches. Crit Rev Oncog. 25:71–94. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Wang Y, Su M, Chen Y, Huang X, Ruan L, Lv
Q and Li L: Research progress on the role and mechanism of DNA
damage repair in germ cell development. Front Endocrinol
(Lausanne). 14:12342802023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Huang Z, Chen Y and Zhang Y: Mitochondrial
reactive oxygen species cause major oxidative mitochondrial DNA
damages and repair pathways. J Biosci. 45:842020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Lad SB, Upadhyay M, Thorat P, Nair D,
Moseley GW, Srivastava S, Pradeepkumar PI and Kondabagil K:
Biochemical reconstitution of the mimiviral base excision repair
pathway. J Mol Biol. 435:1681882023. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Triner D, Devenport SN, Ramakrishnan SK,
Ma X, Frieler RA, Greenson JK, Inohara N, Nunez G, Colacino JA,
Mortensen RM and Shah YM: Neutrophils restrict tumor-associated
microbiota to reduce growth and invasion of colon tumors in mice.
Gastroenterology. 156:1467–1482. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Huang JR, Wang ST, Wei MN, Liu K, Fu JW,
Xing ZH and Shi Z: Piperlongumine alleviates mouse colitis and
colitis-associated colorectal cancer. Front Pharmacol.
11:5868852020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Wang CZ, Zhang CF, Luo Y, Yao H, Yu C,
Chen L, Yuan J, Huang WH, Wan JY, Zeng J, et al: Baicalein, an
enteric microbial metabolite, suppresses gut inflammation and
cancer progression in ApcMin/+ mice. Clin Transl Oncol.
22:1013–1022. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ahlawat S, Kumar P, Mohan H, Goyal S and
Sharma KK: Inflammatory bowel disease: Tri-directional relationship
between microbiota, immune system and intestinal epithelium. Crit
Rev Microbiol. 47:254–273. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Brasiel PGA, Dutra Luquetti SCP, Peluzio
MDCG, Novaes RD and Gonçalves RV: Preclinical evidence of
probiotics in colorectal carcinogenesis: A systematic review. Dig
Dis Sci. 65:3197–3210. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Hor YY, Lew LC, Jaafar MH, Lau AS, Ong JS,
Kato T, Nakanishi Y, Azzam G, Azlan A, Ohno H and Liong MT:
Lactobacillus sp. improved microbiota and metabolite profiles of
aging rats. Pharmacol Res. 146:1043122019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Dong Y, Zhu J, Zhang M, Ge S and Zhao L:
Probiotic Lactobacillus salivarius Ren prevent
dimethylhydrazine-induced colorectal cancer through protein kinase
B inhibition. Appl Microbiol Biotechnol. 104:7377–7389. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Reis SK, Socca EAR, de Souza BR, Genaro
SC, Durán N and Fávaro WJ: Effects of probiotic supplementation on
chronic inflammatory process modulation in colorectal
carcinogenesis. Tissue Cell. 87:1022932024. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Casas-Solís J, Huizar-López MDR,
Irecta-Nájera CA, Pita-López ML and Santerre A: immunomodulatory
effect of lactobacillus casei in a murine model of colon
carcinogenesis. Probiotics Antimicrob Proteins. 12:1012–1024. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Agah S, Alizadeh AM, Mosav M, Ranji P,
Khavari-Daneshvar H, Ghasemian F, Bahmani S and Tavassoli A: More
protection of lactobacillus acidophilus than bifidobacterium
bifidum probiotics on azoxymethane-induced mouse colon cancer.
Probiotics Antimicrob Proteins. 11:857–864. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Samanta S: Potential impacts of prebiotics
and probiotics on cancer prevention. Anticancer Agents Med Chem.
22:605–628. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Abu-Ghazaleh N, Chua WJ and Gopalan V:
Intestinal microbiota and its association with colon cancer and
red/processed meat consumption. J Gastroenterol Hepatol. 36:75–88.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Śliżewska K, Markowiak-Kopeć P and
Śliżewska W: The role of probiotics in cancer prevention. Cancers
(Basel). 13:202020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Yixia Y, Sripetchwandee J, Chattipakorn N
and Chattipakorn SC: The alterations of microbiota and pathological
conditions in the gut of patients with colorectal cancer undergoing
chemotherapy. Anaerobe. 68:1023612021. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Freedman JC, Li J, Mi E and McClane BA:
Identification of an important orphan histidine kinase for the
initiation of sporulation and enterotoxin production by clostridium
perfringens type F strain SM101. mBio. 10:e02674–18. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Ma Y, Qu R, Zhang Y, Jiang C, Zhang Z and
Fu W: Progress in the study of colorectal cancer caused by altered
gut microbiota after cholecystectomy. Front Endocrinol (Lausanne).
13:8159992022. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Nowak A, Śliżewska K, Błasiak J and
Libudzisz Z: The influence of Lactobacillus casei DN 114 001 on the
activity of faecal enzymes and genotoxicity of faecal water in the
presence of heterocyclic aromatic amines. Anaerobe. 30:129–136.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Verma A and Shukla G: Probiotics
lactobacillus rhamnosus GG, lactobacillus acidophilus suppresses
DMH-induced procarcinogenic fecal enzymes and preneoplastic
aberrant crypt foci in early colon carcinogenesis in sprague dawley
rats. Nutr Cancer. 65:84–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhu J, Zhu C, Ge S, Zhang M, Jiang L, Cui
J and Ren F: L actobacillus salivarius Ren prevent the early
colorectal carcinogenesis in 1, 2-dimethylhydrazine-induced rat
model. J Appl Microbiol. 117:208–216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Mohania D, Kansal VK, Sagwal R, Batish VK,
Grover S and Shah D: Anticarcinogenic effect of probiotic dahi and
piroxicam on DMH-induced colorectal carcinogenesis in wistar rats.
American J Cancer Ther Pharm. 1:8–24. 2013.
|
|
109
|
Samara J, Moossavi S, Alshaikh B, Ortega
VA, Pettersen VK, Ferdous T, Hoops SL, Soraisham A, Vayalumkal J,
Dersch-Mills D, et al: Supplementation with a probiotic mixture
accelerates gut microbiome maturation and reduces intestinal
inflammation in extremely preterm infants. Cell Host Microbe.
30:696–711.e5. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Drago L: Probiotics and colon cancer.
Microorganisms. 7:662019. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Eslami M, Yousefi B, Kokhaei P, Hemati M,
Nejad ZR, Arabkari V and Namdar A: Importance of probiotics in the
prevention and treatment of colorectal cancer. J Cell Physiol.
234:17127–17143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Derebasi BN, Davran Bulut S, Aksoy Erden
B, Sadeghian N, Taslimi P and Celebioglu HU: Effects of p-coumaric
acid on probiotic properties of Lactobacillus acidophilus LA-5 and
lacticaseibacillus rhamnosus GG. Arch Microbiol. 206:2232024.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Dos Reis SA, da Conceição LL, Siqueira NP,
Rosa DD, da Silva LL and Peluzio MD: Review of the mechanisms of
probiotic actions in the prevention of colorectal cancer. Nutr Res.
37:1–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Ho Do M, Seo YS and Park HY:
Polysaccharides: Bowel health and gut microbiota. Crit Rev Food Sci
Nutr. 61:1212–1224. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Roberfroid M: Dietary fiber, inulin, and
oligofructose: A review comparing their physiological effects. Crit
Rev Food Sci Nutr. 33:103–148. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Yeung CY, Chiang Chiau JS, Cheng ML, Chan
WT, Chang SW, Chang YH, Jiang CB and Lee HC: Modulations of
probiotics on gut microbiota in a 5-fluorouracil-induced mouse
model of mucositis. J Gastroenterol Hepatol. 35:806–814. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Gavzy SJ, Kensiski A, Lee ZL, Mongodin EF,
Ma B and Bromberg JS: Bifidobacterium mechanisms of immune
modulation and tolerance. Gut Microbes. 15:22911642023. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Gyles CL: Shiga toxin-producing
Escherichia coli: An overview. J Anim Sci. 85:E45–E62. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Pearce SC, Weber GJ, van Sambeek DM,
Soares JW, Racicot K and Breault DT: Intestinal enteroids
recapitulate the effects of short-chain fatty acids on the
intestinal epithelium. PLoS One. 15:e02302312020. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Ji J and Yang H: Using probiotics as
supplementation for Helicobacter pylori antibiotic therapy. Int J
Mol Sci. 21:11362020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Fayol-Messaoudi D, Berger CN,
Coconnier-Polter MH, Liévin-Le Moal V and Servin AL: pH-, Lactic
acid-, and non-lactic acid-dependent activities of probiotic
lactobacilli against salmonella enterica serovar typhimurium. Appl
Environ Microbiol. 71:6008–6013. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Li Y, Yang S, Lun J, Gao J, Gao X, Gong Z,
Wan Y, He X and Cao H: Inhibitory effects of the lactobacillus
rhamnosus GG effector Protein HM0539 on inflammatory response
through the TLR4/MyD88/NF-ĸB axis. Front Immunol. 11:5514492020.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Paone P and Cani PD: Mucus barrier, mucins
and gut microbiota: The expected slimy partners? Gut. 69:2232–2243.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Olli KE, Rapp C, O'Connell L, Collins CB,
McNamee EN, Jensen O, Jedlicka P, Allison KC, Goldberg MS, Gerich
ME, et al: Muc5ac expression protects the colonic barrier in
experimental colitis. Inflamm Bowel Dis. 26:1353–1367. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Kufe DW: MUC1-C in chronic inflammation
and carcinogenesis; emergence as a target for cancer treatment.
Carcinogenesis. 41:1173–1183. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Martens EC, Neumann M and Desai MS:
Interactions of commensal and pathogenic microorganisms with the
intestinal mucosal barrier. Nat Rev Microbiol. 16:457–470. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Etienne-Mesmin L, Chassaing B, Desvaux M,
De Paepe K, Gresse R, Sauvaitre T, Forano E, de Wiele TV, Schüller
S, Juge N and Blanquet-Diot S: Experimental models to study
intestinal microbes-mucus interactions in health and disease. FEMS
Microbiol Rev. 43:457–489. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Fang J, Wang H, Zhou Y, Zhang H, Zhou H
and Zhang X: Slimy partners: The mucus barrier and gut microbiome
in ulcerative colitis. Exp Mol Med. 53:772–787. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Ohland CL and MacNaughton WK: Probiotic
bacteria and intestinal epithelial barrier function. Am J Physiol
Gastrointest Liver Physiol. 298:G807–G819. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Ren C, Zhang Q, de Haan BJ, Faas MM, Zhang
H and de Vos P: Protective effects of lactic acid bacteria on gut
epithelial barrier dysfunction are toll like receptor 2 and protein
kinase C dependent. Food Funct. 11:1230–1234. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Wan Z, Wang L, Chen Z, Ma X, Yang X, Zhang
J and Jiang Z: In vitro evaluation of swine-derived Lactobacillus
reuteri: Probiotic properties and effects on intestinal porcine
epithelial cells challenged with enterotoxigenic Escherichia coli
K88. J Microbiol Biotechnol. 26:1018–1025. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Gu MJ, Song SK, Lee IK, Ko S, Han SE, Bae
S, Ji SY, Park BC, Song KD, Lee HK, et al: Barrier protection via
Toll-like receptor 2 signaling in porcine intestinal epithelial
cells damaged by deoxynivalnol. Vet Res. 47:252016. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Yang F, Wang A, Zeng X, Hou C, Liu H and
Qiao S: Lactobacillus reuteri I5007 modulates tight junction
protein expression in IPEC-J2 cells with LPS stimulation and in
newborn piglets under normal conditions. BMC Microbiol. 15:322015.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Kim SH, Jeung W, Choi ID, Jeong JW, Lee
DE, Huh CS, Kim GB, Hong SS, Shim JJ, Lee JL, et al: Lactic acid
bacteria improves Peyer's patch cell-mediated immunoglobulin A and
tight-junction expression in a destructed gut microbial
environment. J Microbiol Biotechnol. 26:1035–1045. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Zhao Q and Elson CO: Adaptive immune
education by gut microbiota antigens. Immunology. 154:28–37. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Koboziev I, Webb CR, Furr KL and Grisham
MB: Role of the enteric microbiota in intestinal homeostasis and
inflammation. Free Radic Biol Med. 68:122–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Maldonado Galdeano C, Cazorla SI, Lemme
Dumit JM, Vélez E and Perdigón G: Beneficial effects of probiotic
consumption on the immune system. Ann Nutr Metab. 74:115–124. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Foo NP, Ou Yang H, Chiu HH, Chan HY, Liao
CC, Yu CK and Wang YJ: Probiotics prevent the development of 1,
2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through
suppressed colonic mucosa cellular proliferation and increased
stimulation of macrophages. J Agric Food Chem. 59:13337–13345.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Foey A, Habil N, Strachan A and Beal J:
Lacticaseibacillus casei strain shirota modulates
macrophage-intestinal epithelial cell co-culture barrier integrity,
bacterial sensing and inflammatory cytokines. Microorganisms.
10:20872022. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Wong WY, Chan BD, Sham TT, Lee MM, Chan
CO, Chau CT, Mok DK, Kwan YW and Tai WC: Lactobacillus casei strain
shirota ameliorates dextran sulfate sodium-induced colitis in mice
by increasing taurine-conjugated bile acids and inhibiting NF-κB
signaling via stabilization of IκBα. Front Nutr. 9:8168362022.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Santiago-López L, Hernández-Mendoza A,
Vallejo-Cordoba B, Mata-Haro V, Wall-Medrano A and González-Córdova
AF: Milk fermented with lactobacillus fermentum ameliorates
indomethacin-induced intestinal inflammation: An exploratory study.
Nutrients. 11:16102019. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Muscari I, Fierabracci A, Adorisio S,
Moretti M, Cannarile L, Thi Minh Hong V, Ayroldi E and Delfino DV:
Glucocorticoids and natural killer cells: A suppressive
relationship. Biochem Pharmacol. 198:1149302022. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Fotiadis CI, Stoidis CN, Spyropoulos BG
and Zografos ED: Role of probiotics, prebiotics and synbiotics in
chemoprevention for colorectal cancer. World J Gastroenterol.
14:6453–6457. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Rossi M, Keshavarzian A and Bishehsari F:
Nutraceuticals in colorectal cancer: A mechanistic approach. Eur J
Pharmacol. 833:396–402. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
El-Deeb NM, Yassin AM, Al-Madboly LA and
El-Hawiet A: A novel purified Lactobacillus acidophilus 20079
exopolysaccharide, LA-EPS-20079, molecularly regulates both
apoptotic and NF-κB inflammatory pathways in human colon cancer.
Microb Cell Fact. 17:292018. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Shi Y, Meng L, Zhang C, Zhang F and Fang
Y: Extracellular vesicles of Lacticaseibacillus paracasei PC-H1
induce colorectal cancer cells apoptosis via PDK1/AKT/Bcl-2
signaling pathway. Microbiol Res. 255:1269212021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Jin K, Qian C, Lin J and Liu B:
Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in
tumor-associated immune cells. Front Oncol. 13:10998112023.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Kang YJ, Jang JY, Kwon YH, Lee JH, Lee S,
Park Y, Jung YS, Im E, Moon HR, Chung HY and Kim ND: MHY2245, a
sirtuin inhibitor, induces cell cycle arrest and apoptosis in
HCT116 human colorectal cancer cells. Int J Mol Sci. 23:15902022.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Artale S, Grillo N, Lepori S, Butti C,
Bovio A, Barzaghi S, Colombo A, Castiglioni E, Barbarini L,
Zanlorenzi L, et al: A nutritional approach for the management of
chemotherapy-induced diarrhea in patients with colorectal cancer.
Nutrients. 14:18012022. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Burns AJ and Rowland IR: Antigenotoxicity
of probiotics and prebiotics on faecal water-induced DNA damage in
human colon adenocarcinoma cells. Mutat Res. 551:233–243. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Pop OL, Suharoschi R and Gabbianelli R:
Biodetoxification and protective properties of probiotics.
Microorganisms. 10:12782022. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Zhang XB and Ohta Y: Binding of mutagens
by fractions of the cell wall skeleton of lactic acid bacteria on
mutagens. J Dairy Sci. 74:1477–1481. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Shao X, Xu B, Chen C, Li P and Luo H: The
function and mechanism of lactic acid bacteria in the reduction of
toxic substances in food: A review. Crit Rev Food Sci Nutr.
62:5950–5963. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Nowak A and Libudzisz Z: Ability of
probiotic Lactobacillus casei DN 114001 to bind or/and metabolise
heterocyclic aromatic amines in vitro. Eur J Nutr. 48:419–427.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Terahara M, Meguro S and Kaneko T: Effects
of lactic acid bacteria on binding and absorption of mutagenic
heterocyclic amines. Biosci Biotechnol Biochem. 62:197–200. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Orrhage K, Sillerström E, Gustafsson JA,
Nord CE and Rafter J: Binding of mutagenic heterocyclic amines by
intestinal and lactic acid bacteria. Mutat Res. 311:239–248. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Lázaro Á, Vila-Donat P and Manyes L:
Emerging mycotoxins and preventive strategies related to gut
microbiota changes: Probiotics, prebiotics, and postbiotics-a
systematic review. Food Funct. 15:8998–9023. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Liu L, Xie M and Wei D: Biological
detoxification of mycotoxins: Current status and future advances.
Int J Mol Sci. 23:10642022. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Cuevas-González PF, González-Córdova AF,
Vallejo-Cordoba B, Aguilar-Toalá JE, Hall FG, Urbizo-Reyes UC,
Liceaga AM, Hernandez-Mendoza A and García HS: Protective role of
lactic acid bacteria and yeasts as dietary carcinogen-binding
agents-a review. Crit Rev Food Sci Nutr. 62:160–180. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
El-Nezami HS, Chrevatidis A, Auriola S,
Salminen S and Mykkänen H: Removal of common fusarium toxins in
vitro by strains of lactobacillus and propionibacterium. Food Addit
Contam. 19:680–686. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Zoghi A, Khosravi-Darani K and Sohrabvandi
S: Surface binding of toxins and heavy metals by probiotics. Mini
Rev Med Chem. 14:84–98. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Massoud R and Zoghi A: Potential probiotic
strains with heavy metals and mycotoxins bioremoval capacity for
application in foodstuffs. J Appl Microbiol. 133:1288–1307. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Lopez J and Tait SW: Mitochondrial
apoptosis: Killing cancer using the enemy within. Br J Cancer.
112:957–962. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Su S, Chhabra G, Singh CK, Ndiaye MA and
Ahmad N: PLK1 inhibition-based combination therapies for cancer
management. Transl Oncol. 16:1013322022. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Sankarapandian V, Venmathi Maran BA,
Rajendran RL, Jogalekar MP, Gurunagarajan S, Krishnamoorthy R,
Gangadaran P and Ahn BC: An update on the effectiveness of
probiotics in the prevention and treatment of cancer. Life (Basel).
12:592022.PubMed/NCBI
|
|
166
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Kiraz Y, Adan A, Kartal Yandim M and Baran
Y: Major apoptotic mechanisms and genes involved in apoptosis.
Tumour Biol. 37:8471–8486. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Chen HH, Luo CW, Chen YL, Chiang JY, Huang
CR, Wang YT, Chen CH, Guo J and Yip HK: Probiotic-facilitated
cytokine-induced killer cells suppress peritoneal carcinomatosis
and liver metastasis in colorectal cancer cells. Int J Biol Sci.
20:6162–6180. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Karimi Ardestani S, Tafvizi F and Tajabadi
Ebrahimi M: Heat-killed probiotic bacteria induce apoptosis of
HT-29 human colon adenocarcinoma cell line via the regulation of
Bax/Bcl2 and caspases pathway. Hum Exp Toxicol. 38:1069–1081. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Baghbani-Arani F, Asgary V and Hashemi A:
Cell-free extracts of Lactobacillus acidophilus and Lactobacillus
delbrueckii display antiproliferative and antioxidant activities
against HT-29 cell line. Nutr Cancer. 72:1390–1399. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Cotter PD, Ross RP and Hill C:
Bacteriocins-a viable alternative to antibiotics? Nat Rev
Microbiol. 11:95–105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Konishi H, Fujiya M, Tanaka H, Ueno N,
Moriichi K, Sasajima J, Ikuta K, Akutsu H, Tanabe H and Kohgo Y:
Probiotic-derived ferrichrome inhibits colon cancer progression via
JNK-mediated apoptosis. Nat Commun. 7:123652016. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Thirabunyanon M, Boonprasom P and Niamsup
P: Probiotic potential of lactic acid bacteria isolated from
fermented dairy milks on antiproliferation of colon cancer cells.
Biotechnol Lett. 31:571–576. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Khosrovan Z, Haghighat S and Mahdavi M:
The probiotic bacteria induce apoptosis in breast and colon cancer
cells: An immunostimulatory effect. Immunoregulation. 3:37–50.
2020. View Article : Google Scholar
|
|
175
|
Alshuail N, Alehaideb Z, Alghamdi S,
Suliman R, Al-Eidi H, Ali R, Barhoumi T, Almutairi M, Alwhibi M,
Alghanem B, et al: Achillea fragrantissima (Forssk.) Sch.Bip flower
dichloromethane extract exerts anti-proliferative and pro-apoptotic
properties in human triple-negative breast cancer (MDA-MB-231)
cells: In vitro and in silico studies. Pharmaceuticals (Basel).
15:10602022. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Asoudeh-Fard A, Barzegari A, Dehnad A,
Bastani S, Golchin A and Omidi Y: Lactobacillus plantarum induces
apoptosis in oral cancer KB cells through upregulation of PTEN and
downregulation of MAPK signalling pathways. Bioimpacts. 7:193–198.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Isazadeh A, Hajazimian S, Shadman B,
Safaei S, Bedoustani AB, Chavoshi R, Shanehbandi D, Mashayekhi M,
Nahaei M and Baradaran B: Anti-cancer effects of probiotic
lactobacillus acidophilus for colorectal cancer cell line caco-2
through apoptosis induction. Pharm Sci. 27:262–267. 2021.
View Article : Google Scholar
|
|
178
|
Yavari M and Ahmadizadeh C: Effect of the
cellular extract of co-cultured lactobacillus casei on BAX and
Human β-Defensin 2 genes expression in HT29 cells. Intern Med
Today. 26:364–381. 2020.
|
|
179
|
Małaczewska J and Kaczorek-Łukowska E:
Nisin-A lantibiotic with immunomodulatory properties: A review.
Peptides. 137:1704792021. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Singh A, Alexander SG and Martin S: Gut
microbiome homeostasis and the future of probiotics in cancer
immunotherapy. Front Immunol. 14:11144992023. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Liu YC, Wu CR and Huang TW: Preventive
effect of probiotics on oral mucositis induced by cancer treatment:
A systematic review and meta-analysis. Int J Mol Sci. 23:132682022.
View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Nazir Y, Hussain SA, Abdul Hamid A and
Song Y: Probiotics and their potential preventive and therapeutic
role for cancer, high serum cholesterol, and allergic and HIV
diseases. Biomed Res Int. 2018:34284372018. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Arora M, Baldi A, Kapila N, Bhandari S and
Jeet K: Impact of probiotics and prebiotics on colon cancer:
Mechanistic insights and future approaches. Curr Cancer Ther Rev.
15:27–36. 2019. View Article : Google Scholar
|
|
184
|
Hou H, Chen D, Zhang K, Zhang W, Liu T,
Wang S, Dai X, Wang B, Zhong W and Cao H: Gut microbiota-derived
short-chain fatty acids and colorectal cancer: Ready for clinical
translation? Cancer Lett. 526:225–235. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Zhang S, Wang H and Zhu MJ: A sensitive
GC/MS detection method for analyzing microbial metabolites short
chain fatty acids in fecal and serum samples. Talanta. 196:249–254.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Wong JM, De Souza R, Kendall CW, Emam A
and Jenkins DJ: Colonic health: Fermentation and short chain fatty
acids. J Clin Gastroenterol. 40:235–243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Bhogoju S and Nahashon S: Recent advances
in probiotic application in animal health and nutrition: A review.
Agriculture. 12:3042022. View Article : Google Scholar
|
|
188
|
Encarnação JC, Abrantes AM, Pires AS and
Botelho MF: Revisit dietary fiber on colorectal cancer: Butyrate
and its role on prevention and treatment. Cancer Metastasis Rev.
34:465–478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai
Q and Chen W: Surface components and metabolites of probiotics for
regulation of intestinal epithelial barrier. Microb Cell Fact.
19:232020. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Lu SY, Liu Y, Tang S, Zhang W, Yu Q, Shi C
and Cheong KL: Gracilaria lemaneiformis polysaccharides alleviate
colitis by modulating the gut microbiota and intestinal barrier in
mice. Food Chem X. 13:1001972022. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Ratajczak W, Rył A, Mizerski A,
Walczakiewicz K, Sipak O and Laszczyńska M: Immunomodulatory
potential of gut microbiome-derived short-chain fatty acids
(SCFAs). Acta Biochim Pol. 66:1–12. 2019.PubMed/NCBI
|
|
192
|
Yoo JY, Groer M, Dutra SVO, Sarkar A and
McSkimming DI: Gut microbiota and immune system interactions.
Microorganisms. 8:15872020. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Woo V and Alenghat T: Epigenetic
regulation by gut microbiota. Gut Microbes. 14:20224072022.
View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Ruzic D, Djoković N, Srdić-Rajić T,
Echeverria C, Nikolic K and Santibanez JF: Targeting histone
deacetylases: Opportunities for cancer treatment and
chemoprevention. Pharmaceutics. 14:2092022. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Faghfoori Z, Gargari BP, Gharamaleki AS,
Bagherpour H and Khosroushahi AY: Cellular and molecular mechanisms
of probiotics effects on colorectal cancer. J Funct Foods.
18:463–472. 2015. View Article : Google Scholar
|
|
196
|
Sanaei M and Kavoosi F: Effect of sodium
butyrate on p16INK4a, p14ARF, p15INK4b, Class I HDACs (HDACs 1, 2,
3) Class II HDACs (HDACs 4, 5, 6), Cell growth inhibition and
apoptosis induction in pancreatic cancer AsPC-1 and colon cancer
HCT-116 cell lines. Asian Pac J Cancer Prev. 23:795–802. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Chai L, Luo Q, Cai K, Wang K and Xu B:
Reduced fecal short-chain fatty acids levels and the relationship
with gut microbiota in IgA nephropathy. BMC Nephrol. 22:2092021.
View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Piotrowska M, Binienda A and Fichna J: The
role of fatty acids in Crohn's disease pathophysiology-An overview.
Mol Cell Endocrinol. 538:1114482021. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Haase S, Haghikia A, Wilck N, Müller DN
and Linker RA: Impacts of microbiome metabolites on immune
regulation and autoimmunity. Immunology. 154:230–238. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Ni D, Tan J, Niewold P, Spiteri AG, Pinget
GV, Stanley D, King NJC and Macia L: Impact of dietary fiber on
west nile virus infection. Front Immunol. 13:7844862022. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Shanmugam G, Rakshit S and Sarkar K: HDAC
inhibitors: Targets for tumor therapy, immune modulation and lung
diseases. Transl Oncol. 16:1013122022. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Lee SY, Kang JH, Kim JH, Jeong JW, Kim HW,
Oh DH, Yoon SH and Hur SJ: Relationship between gut microbiota and
colorectal cancer: Probiotics as a potential strategy for
prevention. Food Res Int. 156:1113272022. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Althagafi HA: The potential anticancer
potency of kolaviron on colorectal adenocarcinoma (Caco-2) cells.
Anticancer Agents Med Chem. 24:1097–1108. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Jiang X, Li S, Qiu X, Cong J, Zhou J and
Miu W: Curcumin inhibits cell viability and increases apoptosis of
SW620 human colon adenocarcinoma cells via the caudal type
homeobox-2 (CDX2)/Wnt/β-catenin pathway. Med Sci Monit.
25:7451–7458. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Huang C, Deng W, Xu HZ, Zhou C, Zhang F,
Chen J, Bao Q, Zhou X, Liu M, Li J and Liu C: Short-chain fatty
acids reprogram metabolic profiles with the induction of reactive
oxygen species production in human colorectal adenocarcinoma cells.
Comput Struct Biotechnol J. 21:1606–1620. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Zeng H, Hamlin SK, Safratowich BD, Cheng
WH and Johnson LK: Superior inhibitory efficacy of butyrate over
propionate and acetate against human colon cancer cell
proliferation via cell cycle arrest and apoptosis: Linking dietary
fiber to cancer prevention. Nutr Res. 83:63–72. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Aziz T, Sarwar A, Daudzai Z, Naseeb J, Din
JU, Aftab U, Saidal A, Ghani M, Khan AA, Naz S, et al: Conjugated
fatty acids (CFAS) production via various bacterial strains and
their applications. A review. J Chil Chem Soc. 67:5445–5452. 2022.
View Article : Google Scholar
|
|
208
|
Wu C, Chen H, Mei Y, Yang B, Zhao J,
Stanton C and Chen W: Advances in research on microbial conjugated
linoleic acid bioconversion. Prog Lipid Res. 93:1012572024.
View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Liu XX, Zhang HY, Song X, Yang Y, Xiong
ZQ, Xia YJ and Ai LZ: Reasons for the differences in
biotransformation of conjugated linoleic acid by Lactobacillus
plantarum. J Dairy Sci. 104:11466–11473. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Qian Y, Chun ZJ, Liu ZY and Xu L:
Probiotics in gastrointestinal cancer: Antitumoral effects and
molecular mechanisms of action. Zhonghua Nei Ke Za Zhi.
61:1167–1171. 2022.(In Chinese). PubMed/NCBI
|
|
211
|
Cho HJ, Kim WK, Kim EJ, Jung KC, Park S,
Lee HS, Tyner AL and Park JH: Conjugated linoleic acid inhibits
cell proliferation and ErbB3 signaling in HT-29 human colon cell
line. Am J Physiol Gastrointest Liver Physiol. 284:G996–G1005.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Chen Y, Ma W, Zhao J, Stanton C, Ross RP,
Zhang H, Chen W and Yang B: Lactobacillus plantarum ameliorates
colorectal cancer by ameliorating the intestinal barrier through
the CLA-PPAR-γ axis. J Agric Food Chem. 72:19766–19785. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Dachev M, Bryndová J, Jakubek M, Moučka Z
and Urban M: The effects of conjugated linoleic acids on cancer.
Processes. 9:4542021. View Article : Google Scholar
|
|
214
|
Shahzad MMK, Felder M, Ludwig K, Van
Galder HR, Anderson ML, Kim J, Cook ME, Kapur AK and Patankar MS:
Trans10, cis12 conjugated linoleic acid inhibits proliferation and
migration of ovarian cancer cells by inducing ER stress, autophagy,
and modulation of Src. PLoS One. 13:e01895242018. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Badawy S, Liu Y, Guo M, Liu Z, Xie C,
Marawan MA, Ares I, Lopez-Torres B, Martínez M, Maximiliano JE, et
al: Conjugated linoleic acid (CLA) as a functional food: Is it
beneficial or not? Food Res Int. 172:1131582023. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Saber A, Alipour B, Faghfoori Z and Yari
Khosroushahi A: Cellular and molecular effects of yeast probiotics
on cancer. Crit Rev Microbiol. 43:96–115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Basak S and Duttaroy AK: Conjugated
linoleic acid and its beneficial effects in obesity, cardiovascular
disease, and cancer. Nutrients. 12:19132020. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Mei Y, Chen H, Yang B, Zhao J, Zhang H and
Chen W: Research progress on conjugated linoleic acid
bio-conversion in Bifidobacterium. Int J Food Microbiol.
369:1095932022. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Chen Y, Yang B, Ross RP, Jin Y, Stanton C,
Zhao J, Zhang H and Chen W: Orally administered CLA ameliorates
DSS-induced colitis in mice via intestinal barrier improvement,
oxidative stress reduction, and inflammatory cytokine and gut
microbiota modulation. J Agric Food Chem. 67:13282–13298. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Cruz BCS, Sarandy MM, Messias AC,
Gonçalves RV, Ferreira CLLF and Peluzio MCG: Preclinical and
clinical relevance of probiotics and synbiotics in colorectal
carcinogenesis: A systematic review. Nutr Rev. 78:667–687. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Żółkiewicz J, Marzec A, Ruszczyński M and
Feleszko W: Postbiotics-A step beyond pre- and probiotics.
Nutrients. 12:21892020. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Chen P, Yang C, Ren K, Xu M, Pan C, Ye X
and Li L: Modulation of gut microbiota by probiotics to improve the
efficacy of immunotherapy in hepatocellular carcinoma. Front
Immunol. 15:15049482024. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
De Souza JB, Brelaz-de-Castro MCA and
Cavalcanti IMF: Strategies for the treatment of colorectal cancer
caused by gut microbiota. Life Sci. 290:1202022022. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Wang P, Jia Y, Wu R, Chen Z and Yan R:
Human gut bacterial β-glucuronidase inhibition: An emerging
approach to manage medication therapy. Biochem Pharmacol.
190:1145662021. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Josephy PD and Allen-Vercoe E: Reductive
metabolism of azo dyes and drugs: Toxicological implications. Food
Chem Toxicol. 178:1139322023. View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Molska M and Reguła J: Potential
mechanisms of probiotics action in the prevention and treatment of
colorectal cancer. Nutrients. 11:24532019. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Nowak A, Paliwoda A and Błasiak J:
Anti-proliferative, pro-apoptotic and anti-oxidative activity of
Lactobacillus and Bifidobacterium strains: A review of mechanisms
and therapeutic perspectives. Crit Rev Food Sci Nutr. 59:3456–3467.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
De Roos NM and Katan MB: Effects of
probiotic bacteria on diarrhea, lipid metabolism, and
carcinogenesis: A review of papers published between 1988 and 1998.
Am J Clin Nutr. 71:405–411. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Jacquier EF, van de Wouw M, Nekrasov E,
Contractor N, Kassis A and Marcu D: Local and systemic effects of
bioactive food ingredients: Is there a role for functional foods to
prime the gut for resilience? Foods. 13:7392024. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Phannasorn W, Pharapirom A, Thiennimitr P,
Guo H, Ketnawa S and Wongpoomchai R: Enriched riceberry bran oil
exerts chemopreventive properties through anti-inflammation and
alteration of gut microbiota in carcinogen-induced liver and colon
carcinogenesis in rats. Cancers (Basel). 14:43582022. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Walia S, Kamal R, Kanwar SS and Dhawan DK:
Hepato-protective role of chemo-preventive probiotics during
DMH-induced CRC in rats. J Biochem Mol Toxicol. 35:e227882021.
View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Vougiouklaki D, Tsironi T, Tsantes AG,
Tsakali E, Van Impe JFM and Houhoula D: Probiotic properties and
antioxidant activity in vitro of lactic acid bacteria.
Microorganisms. 11:12642023. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Guo Y, Huang R, Niu Y, Zhang P, Li Y and
Zhang W: Chemical characteristics, antioxidant capacity, bacterial
community, and metabolite composition of mulberry silage ensiling
with lactic acid bacteria. Front Microbiol. 15:13632562024.
View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Mobasherpour P, Yavarmanesh M and
Edalatian Dovom MR: Antitumor properties of traditional lactic acid
bacteria: Short-chain fatty acid production and interleukin 12
induction. Heliyon. 10:e361832024. View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Tang C and Lu Z: Health promoting
activities of probiotics. J Food Biochem. 43:e129442019. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Martínez FG, Cuencas Barrientos ME, Mozzi
F and Pescuma M: Survival of selenium-enriched lactic acid bacteria
in a fermented drink under storage and simulated gastro-intestinal
digestion. Food Res Int. 123:115–124. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Tsivileva O, Shaternikov A and Evseeva N:
Basidiomycetes polysaccharides regulate growth and antioxidant
defense system in wheat. Int J Mol Sci. 25:68772024. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Salimi F and Farrokh P: Recent advances in
the biological activities of microbial exopolysaccharides. World J
Microbiol Biotechnol. 39:2132023. View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Zhang J, Xiao Y, Wang H, Zhang H, Chen W
and Lu W: Lactic acid bacteria-derived exopolysaccharide:
Formation, immunomodulatory ability, health effects, and
structure-function relationship. Microbiol Res. 274:1274322023.
View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Adesulu-Dahunsi AT, Sanni AI and Jeyaram
K: Production, characterization and in vitro antioxidant activities
of exopolysaccharide from Weissella cibaria GA44. LWT. 87:432–442.
2018. View Article : Google Scholar
|
|
241
|
Dougherty MW and Jobin C: Intestinal
bacteria and colorectal cancer: Etiology and treatment. Gut
Microbes. 15:21850282023. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Kang X, Liu C, Ding Y, Ni Y, Ji F, Lau
HCH, Jiang L, Sung JJ, Wong SH and Yu J: Roseburia intestinalis
generated butyrate boosts anti-PD-1 efficacy in colorectal cancer
by activating cytotoxic CD8+ T cells. Gut. 72:2112–2122. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
243
|
Zhao J, Liao Y, Wei C, Ma Y, Wang F, Chen
Y, Zhao B, Ji H, Wang D and Tang D: Potential ability of probiotics
in the prevention and treatment of colorectal cancer. Clin Med
Insights Oncol. 17:117955492311882252023. View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Jain S, Purohit A, Nema P, Vishwakarma H,
Qureshi A and kumar JP: Pathways of targeted therapy for colorectal
cancer. J Drug Delivery Ther. 12:217–221. 2022. View Article : Google Scholar
|
|
245
|
Chrysostomou D, Roberts LA, Marchesi JR
and Kinross JM: Gut Microbiota modulation of efficacy and toxicity
of cancer chemotherapy and immunotherapy. Gastroenterology.
164:198–213. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
246
|
Lu L, Dong J, Liu Y, Qian Y, Zhang G, Zhou
W, Zhao A, Ji G and Xu H: New insights into natural products that
target the gut microbiota: Effects on the prevention and treatment
of colorectal cancer. Front Pharmacol. 13:9647932022. View Article : Google Scholar : PubMed/NCBI
|
|
247
|
Guo Y, Wang M, Zou Y, Jin L, Zhao Z, Liu
Q, Wang S and Li J: Mechanisms of chemotherapeutic resistance and
the application of targeted nanoparticles for enhanced chemotherapy
in colorectal cancer. J Nanobiotechnology. 20:3712022. View Article : Google Scholar : PubMed/NCBI
|
|
248
|
Kouidhi S, Zidi O, Belkhiria Z, Rais H,
Ayadi A, Ben Ayed F, Mosbah A, Cherif A and El Gaaied ABA: Gut
microbiota, an emergent target to shape the efficiency of cancer
therapy. Explor Target Antitumor Ther. 4:240–265. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
249
|
Mahdy MS, Azmy AF, Dishisha T, Mohamed WR,
Ahmed KA, Hassan A, Aidy SE and El-Gendy AO: Irinotecan-gut
microbiota interactions and the capability of probiotics to
mitigate Irinotecan-associated toxicity. BMC Microbiol. 23:532023.
View Article : Google Scholar : PubMed/NCBI
|
|
250
|
Ren Z, Chen S, Lv H, Peng L, Yang W, Chen
J, Wu Z and Wan C: Effect of Bifidobacterium animalis subsp. lactis
SF on enhancing the tumor suppression of irinotecan by regulating
the intestinal flora. Pharmacol Res. 184:1064062022. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Cai B, Pan J, Chen H, Chen X, Ye Z, Yuan
H, Sun H and Wan P: Oyster polysaccharides ameliorate intestinal
mucositis and improve metabolism in 5-fluorouracil-treated S180
tumour-bearing mice. Carbohydr Polym. 256:1175452021. View Article : Google Scholar : PubMed/NCBI
|
|
252
|
Capurso L: Thirty years of Lactobacillus
rhamnosus GG: A review. J Clin Gastroenterol. 53:S1–S41. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
253
|
He Y, Fu L, Li Y, Wang W, Gong M, Zhang J,
Dong X, Huang J, Wang Q, Mackay CR, et al: Gut microbial
metabolites facilitate anticancer therapy efficacy by modulating
cytotoxic CD8+ T cell immunity. Cell Metab. 33:988–1000. e72021.
View Article : Google Scholar : PubMed/NCBI
|
|
254
|
He Y, Ling Y, Zhang Z, Mertens RT, Cao Q,
Xu X, Guo K, Shi Q, Zhang X, Huo L, et al: Butyrate reverses
ferroptosis resistance in colorectal cancer by inducing
c-Fos-dependent xCT suppression. Redox Biol. 65:1028222023.
View Article : Google Scholar : PubMed/NCBI
|
|
255
|
Khorashadizadeh S, Abbasifar S, Yousefi M,
Fayedeh F and Moodi Ghalibaf A: The role of microbiome and
probiotics in chemo-radiotherapy-induced diarrhea: A narrative
review of the current evidence. Cancer Rep (Hoboken). 7:e700292024.
View Article : Google Scholar : PubMed/NCBI
|
|
256
|
Moraitis I, Guiu J and Rubert J: Gut
microbiota controlling radiation-induced enteritis and intestinal
regeneration. Trends Endocrinol Metab. 34:489–501. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
257
|
Long L, Zhang Y, Zang J, Liu P, Liu W, Sun
C, Tian D, Li P, Tian J and Xiao J: Investigating the relationship
between postoperative radiotherapy and intestinal flora in rectal
cancer patients: A study on efficacy and radiation enteritis. Front
Oncol. 14:14084362024. View Article : Google Scholar : PubMed/NCBI
|
|
258
|
Gonzalez-Mercado VJ, Henderson WA, Sarkar
A, Lim J, Saligan LN, Berk L, Dishaw L, McMillan S, Groer M,
Sepehri F and Melkus GD: Changes in gut microbiome associated with
co-occurring symptoms development during chemo-radiation for rectal
cancer: A proof of concept study. Biol Res Nurs. 23:31–41. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
259
|
Al-Qadami G, Van Sebille Y, Le H and Bowen
J: Gut microbiota: implications for radiotherapy response and
radiotherapy-induced mucositis. Expert Rev Gastroenterol Hepatol.
13:485–496. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
260
|
Sun CH, Li BB, Wang B, Zhao J, Zhang XY,
Li TT, Li WB, Tang D, Qiu MJ, Wang XC, et al: The role of
Fusobacterium nucleatum in colorectal cancer: From carcinogenesis
to clinical management. Chronic Dis Transl Med. 5:178–187.
2019.PubMed/NCBI
|
|
261
|
Jin Y, Wang J and Wang Y: Unraveling the
complexity of radiotherapy- and chemotherapy-induced oral
mucositis: Insights into pathogenesis and intervention strategies.
Support Care Cancer. 33:1952025. View Article : Google Scholar : PubMed/NCBI
|
|
262
|
Wang K, Zhang J, Zhang Y, Xue J, Wang H,
Tan X, Jiao X and Jiang H: The recovery of intestinal barrier
function and changes in oral microbiota after radiation therapy
injury. Front Cell Infect Microbiol. 13:12886662024. View Article : Google Scholar : PubMed/NCBI
|
|
263
|
Chen QY, Tian HL, Yang B, Lin ZL, Zhao D,
Ye C, Zhang XY, Qin HL and Li N: Effect of intestinal preparation
on the efficacy and safety of fecal microbiota transplantation
treatment. Zhonghua Wei Chang Wai Ke Za Zhi. 23:48–55. 2020.(In
Chinese). PubMed/NCBI
|
|
264
|
Al Zein M, Boukhdoud M, Shammaa H, Mouslem
H, El Ayoubi LM, Iratni R, Issa K, Khachab M, Assi HI, Sahebkar A
and Eid AH: Immunotherapy and immunoevasion of colorectal cancer.
Drug Discov Today. 28:1036692023. View Article : Google Scholar : PubMed/NCBI
|
|
265
|
Sun BL: Current microsatellite instability
testing in management of colorectal cancer. Clin Colorectal Cancer.
20:e12–e20. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
266
|
Guo R, Li J, Hu J, Fu Q, Yan Y, Xu S, Wang
X and Jiao F: Combination of epidrugs with immune checkpoint
inhibitors in cancer immunotherapy: From theory to therapy. Int
Immunopharmacol. 120:1104172023. View Article : Google Scholar : PubMed/NCBI
|
|
267
|
Salek Farrokhi A, Darabi N, Yousefi B,
Askandar RH, Shariati M and Eslami M: Is it true that gut
microbiota is considered as panacea in cancer therapy? J Cell
Physiol. 234:14941–14950. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
268
|
Wu J, Wang S, Zheng B, Qiu X, Wang H and
Chen L: Modulation of gut microbiota to enhance effect of
checkpoint inhibitor immunotherapy. Front Immunol. 12:6691502021.
View Article : Google Scholar : PubMed/NCBI
|
|
269
|
Zhao H, Wang D, Zhang Z, Xian J and Bai X:
Effect of gut microbiota-derived metabolites on immune checkpoint
inhibitor therapy: Enemy or friend? Molecules. 27:47992022.
View Article : Google Scholar : PubMed/NCBI
|
|
270
|
Xie Y and Liu F: The role of the gut
microbiota in tumor, immunity, and immunotherapy. Front Immunol.
15:14109282024. View Article : Google Scholar : PubMed/NCBI
|
|
271
|
Aghamajidi A and Maleki Vareki S: The
effect of the gut microbiota on systemic and anti-tumor immunity
and response to systemic therapy against cancer. Cancers (Basel).
14:35632022. View Article : Google Scholar : PubMed/NCBI
|
|
272
|
Yang J, Yang H and Li Y: The triple
interactions between gut microbiota, mycobiota and host immunity.
Crit Rev Food Sci Nutr. 63:11604–11624. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
273
|
Noguera-Fernández N, Candela-González J
and Orenes-Piñero E: Probiotics, prebiotics, fecal microbiota
transplantation, and dietary patterns in inflammatory bowel
disease. Mol Nutr Food Res. 68:e24004292024. View Article : Google Scholar : PubMed/NCBI
|
|
274
|
Yadegar A, Bar-Yoseph H, Monaghan TM,
Pakpour S, Severino A, Kuijper EJ, Smits WK, Terveer EM, Neupane S,
Nabavi-Rad A, et al: Fecal microbiota transplantation: Current
challenges and future landscapes. Clin Microbiol Rev.
37:e00060222024. View Article : Google Scholar : PubMed/NCBI
|
|
275
|
Selvamani S, Mehta V, Ali El Enshasy H,
Thevarajoo S, El Adawi H, Zeini I, Pham K, Varzakas T and Abomoelak
B: Efficacy of probiotics-based interventions as therapy for
inflammatory bowel disease: A recent update. Saudi J Biol Sci.
29:3546–3567. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
276
|
Wang JW, Kuo CH, Kuo FC, Wang YK, Hsu WH,
Yu FJ, Hu HM, Hsu PI, Wang JY and Wu DC: Fecal microbiota
transplantation: Review and update. J Formos Med Assoc. 118 (Suppl
1):S23–S31. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
277
|
Yu H, Li XX, Han X, Chen BX, Zhang XH, Gao
S, Xu DQ, Wang Y, Gao ZK, Yu L, et al: Fecal microbiota
transplantation inhibits colorectal cancer progression: Reversing
intestinal microbial dysbiosis to enhance anti-cancer immune
responses. Front Microbiol. 14:11268082023. View Article : Google Scholar : PubMed/NCBI
|
|
278
|
Chang CW, Lee HC, Li LH, Chiang Chiau JS,
Wang TE, Chuang WH, Chen MJ, Wang HY, Shih SC, Liu CY, et al: Fecal
microbiota transplantation prevents intestinal injury, upregulation
of toll-like receptors, and 5-fluorouracil/oxaliplatin-induced
toxicity in colorectal cancer. Int J Mol Sci. 21:3862020.
View Article : Google Scholar : PubMed/NCBI
|
|
279
|
Pi Y, Wu Y, Zhang X, Lu D, Han D, Zhao J,
Zheng X, Zhang S, Ye H, Lian S, et al: Gut microbiota-derived
ursodeoxycholic acid alleviates low birth weight-induced colonic
inflammation by enhancing M2 macrophage polarization. Microbiome.
11:192023. View Article : Google Scholar : PubMed/NCBI
|
|
280
|
Song Q, Gao Y, Liu K, Tang Y, Man Y and Wu
H: Gut microbial and metabolomics profiles reveal the potential
mechanism of fecal microbiota transplantation in modulating the
progression of colitis-associated colorectal cancer in mice. J
Transl Med. 22:10282024. View Article : Google Scholar : PubMed/NCBI
|
|
281
|
Wu R, Xiong R, Li Y, Chen J and Yan R: Gut
microbiome, metabolome, host immunity associated with inflammatory
bowel disease and intervention of fecal microbiota transplantation.
J Autoimmun. 141:1030622023. View Article : Google Scholar : PubMed/NCBI
|
|
282
|
Xu H, Cao C, Ren Y, Weng S, Liu L, Guo C,
Wang L, Han X, Ren J and Liu Z: Antitumor effects of fecal
microbiota transplantation: Implications for microbiome modulation
in cancer treatment. Front Immunol. 13:9494902022. View Article : Google Scholar : PubMed/NCBI
|
|
283
|
Perillo F, Amoroso C, Strati F, Giuffrè
MR, Díaz-Basabe A, Lattanzi G and Facciotti F: Gut microbiota
manipulation as a tool for colorectal cancer management: Recent
advances in its use for therapeutic purposes. Int J Mol Sci.
21:53892020. View Article : Google Scholar : PubMed/NCBI
|
